Small Molecules

20 Oct 2020 Treadwell Announces Initiation of New Clinical Trial of CFI-400945 in Patients with Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
20 Oct 2020 Aptinyx Reports Positive, Statistically Significant, Top-line Data From Phase 2 Study of NYX-783 in Patients With Post-Traumatic Stress Disorder
20 Oct 2020 ORIC Pharmaceuticals Expands Precision Oncology Pipeline with Exclusive License to Brain Penetrant EGFR/HER2 Exon 20 Inhibitor Program
20 Oct 2020 Tagrisso granted Priority Review in the US for the adjuvant treatment of patients with early-stage EGFR-mutated lung cancer
19 Oct 2020 AbbVie Submits Regulatory Applications to FDA and EMA for RINVOQ™ (upadacitinib) in Atopic Dermatitis
19 Oct 2020 Aptose Initiates Dosing of CG-806 in Patients with Acute Myeloid Leukemia
19 Oct 2020 Cocrystal Pharma Provides Update on Influenza A Program
19 Oct 2020 Forxiga recommended for approval in the EU by CHMP for heart failure
19 Oct 2020 Trixeo Aerosphere recommended for approval in the EU by CHMP for the maintenance treatment of COPD
17 Oct 2020 Agios Announces Withdrawal of European Marketing Authorization Application for TIBSOVO® as a Treatment for Relapsed or Refractory IDH1-mutant Acute Myeloid Leukemia
17 Oct 2020 ViiV Healthcare receives positive CHMP opinion for long-acting regimen for the treatment of HIV
17 Oct 2020 Genentech Announces Full FDA Approval for Venclexta Combinations for Acute Myeloid Leukemia
16 Oct 2020 Imara Announces First Patient Dosed in Forte Phase 2b Clinical Trial of IMR-687 in Beta-Thalassemia
16 Oct 2020 Janssen Receives Positive CHMP Opinion for Long-Acting Regimen for the Treatment of HIV
16 Oct 2020 Astex and Otsuka Announce Results of Phase 3 ASTRAL-2 and ASTRAL-3 Studies of Guadecitabine (SGI-110) in Patients with Previously Treated Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia (MDS/CMML)
16 Oct 2020 Confo Therapeutics Announces Selection of First Product Candidate and Initiation of Pre-Clinical Development
16 Oct 2020 Sage Therapeutics Announces Positive Interim, Topline Zuranolone Safety and Tolerability Data from Open-Label SHORELINE Study in Patients with MDD
16 Oct 2020 Lipella Pharmaceuticals Initiates Its Phase-2a Clinical Trial of LP-10 for Hemorrhagic Cystitis
16 Oct 2020 Galapagos and Servier report topline results for ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients
15 Oct 2020 GNT Pharma Announces Positive Top-Line Results in a Phase II Study of Nelonemdaz for Acute Ischemic Stroke Patients Treated With Endovascular Thrombectomy
15 Oct 2020 Vertex Provides Update on its Clinical Programs Targeting Alpha-1 Antitrypsin Deficiency
14 Oct 2020 Arvinas Announces Pipeline Programs Targeting Validated and Classically “Undruggable” Disease-Causing Proteins
14 Oct 2020 Harmony Biosciences Receives FDA Approval For Expanded Use Of WAKIX® (pitolisant) For The Treatment Of Cataplexy In Adult Patients With Narcolepsy
14 Oct 2020 Cyclerion Announces Phase 2 STRONG-SCD Study Results in Patients with Sickle Cell Disease
14 Oct 2020 Polyphor receives CARB-X award of up to USD 18.44 million to support development of new antibiotic program

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up